Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Apr 15 1999
WASHINGTON, D.C. (April 15, 1999) Genomics is revolutionizing biology and biotechnology research, greatly accelerating the discovery of new therapies...
Apr 8 1999
WASHINGTON, D.C.(April 8, 1999) Heart disease claims 10 times as many lives as breast cancer and 42 percent of women die within a year of a heart attack...
Apr 8 1999
WASHINGTON, D.C.(April 8, 1999) BIO's board of directors approved a statement opposing discriminatory misuse of medical information, including all...
Mar 31 1999
  WASHINGTON, D.C., (March 31, 1999) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on...
Mar 31 1999
March 31, 1999 (Washington, D.C.) - Environmentally sustainable agriculture and great tasting, more healthful foods are the focus of "Agriculture...
Mar 29 1999
BIO's board of directors has approved a Medicare Modernization Position, which gives BIO a clear standard with which to evaluate all Medicare...
Mar 16 1999
Washington, D.C. (March 16, 1999) The Biotechnology Industry Organization (BIO) today honored Massachusetts Rep. Lida E. Harkins (D-Needham) as BIO State...
Mar 16 1999
  Washington, DC(March 16, 1999) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in...
Mar 15 1999
March 15, 1999 (Washington, D.C.) - The first-ever analysis of biotechnology's impact on crop protection and benefits to the environment finds...


Biotechnology News

August 27, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology Announces 1:100 Reverse Stock Split

August 27, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small...

August 27, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group comments on inaccurate article. The author disclosed on the front page that he is “short” the Company’s stock, meaning...

August 27, 2014

MADISON, Wis.--(BUSINESS WIRE)--Madison Vaccines Inc.'s MVI-816 will be used in a trial testing a two-pronged approach to treat metastatic prostate cancer, conducted with...

August 27, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced that a series of abstracts highlighting data from its Infectious Disease portfolio...